Arboviral diseases in pediatrics

Martins, Marlos Melo; Prata‐Barbosa, Arnaldo; Cunha, Antonio José Ledo Alves da

doi:10.1016/j.jped.2019.08.005

Cited by 11 publications

(4 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…MAYV is transmitted by Haemagogus , Culex , Mansonia , Aedes , Psorophora , Sabethes , and Coquillettidia mosquitos [ 36 , 37 ]. It is the only known arthritogenic new world alphavirus [ 38 ].…”

Section: Epidemiology Of Alphavirus Infectionmentioning

confidence: 99%

Persistent Joint Pain Following Arthropod Virus Infections

et al. 2021

View full text Add to dashboard Cite

Purpose of Review Persistent joint pain is a common manifestation of arthropod-borne viral infections and can cause long-term disability. We review the epidemiology, pathophysiology, diagnosis, and management of arthritogenic alphavirus infection. Recent findings The global re-emergence of alphaviral outbreaks has led to an increase in virus-induced arthralgia and arthritis. Alphaviruses, including Chikungunya, O’nyong’nyong, Sindbis, Barmah Forest, Ross River, and Mayaro viruses, are associated with acute and/or chronic rheumatic symptoms. Identification of Mxra8 as a viral entry receptor in the alphaviral replication pathway creates opportunities for treatment and prevention. Recent evidence suggesting virus does not persist in synovial fluid during chronic chikungunya infection indicates that immunomodulators may be given safely. Summary The etiology of persistent joint pain after alphavirus infection is still poorly understood. New diagnostic tools along and evidence-based treatment could significantly improve morbidity and long-term disability.

show abstract

Section: Epidemiology Of Alphavirus Infectionmentioning

confidence: 99%

Persistent Joint Pain Following Arthropod Virus Infections

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Currently, there are still no safe and effective vaccines or medicines to prevent or treat all the arboviruses carried by these vectors, except for yellow fever [26,27]. Thus, measures adopted to control these diseases must consist of actions to reduce vector circulation and, consequently, viral circulation [26,28].…”

Section: Plos Neglected Tropical Diseasesmentioning

confidence: 99%

New traps for the capture of Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse) (Diptera: Culicidae) eggs and adults

Silva

et al. 2021

PLoS Negl Trop Dis

View full text Add to dashboard Cite

The control of arboviruses carried by Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse) can be performed with tools that monitor and reduce the circulation of these vectors. Therefore, the efficiency of four types of traps in capturing A. aegypti and A. albopictus eggs and adults, with the biological product Vectobac WG, was evaluated in the field. For this, 20 traps were installed in two locations, which were in the South (Londrina, Paraná) and North (Manaus, Amazonas) Regions of Brazil, from March to April 2017 and January to February 2018, respectively. The UELtrap-E (standard trap) and UELtrap-EA traps captured A. aegypti and A. albopictus eggs: 1703/1866 eggs in Londrina, and 10268/2149 eggs in Manaus, respectively, and presented high ovitraps positivity index (OPI) values (averages: 100%/100% in Londrina, and 100%/96% in Manaus, respectively); and high egg density index (EDI) values (averages: 68/75 in Londrina, and 411/89 in Manaus, respectively), so they had statistically superior efficiency to that of the CRtrap-E and CRtrap-EA traps in both regions, that captured less eggs and adults: 96/69 eggs in Londrina, and 1091/510 eggs in Manaus, respectively. Also presented lower OPI values (averages: 28%/4% in Londrina, and 88%/60% in Manaus, respectively); and lower EDI values (averages: 10.5/9 in Londrina, and 47/30 in Manaus, respectively). The capture ratios of Aedes adults in the UELtrap-EA and CRtrap-EA traps in Londrina and Manaus were 53.3%/29.5% and 0%/9.8%, respectively. UELtrap-EA can be adopted as efficient tool for Aedes monitoring due to their high sensitivity, low cost and ease of use.

show abstract

“…During this period, infected patients may present clinical signs, such as a rash, fever, nausea, vomiting, myalgia, and bilateral arthralgia, mainly in the phalanges, wrists, and ankles 4,5 . The chronic form, on the other hand, occurs in 3 or more months, and is characterized by the persistence of arthralgia, which can be incapacitating and affect the quality of life of the individual 6 .…”

Section: Introductionmentioning

confidence: 99%

Chikungunya Hospitalization In The Pediatric Population In Brazil: 2017-2021

Vedana¹,

Alvarenga²,

Braga³

et al. 2023

Collection of International Topics in Health Science- V1

View full text Add to dashboard Cite

Chikungunya is a viral disease caused by the pathogen of the same name, of the Alphavirus genus, which can infect humans through the bite of an infected female Aedes aegypti mosquito and Aedes albopictus, the same as dengue. In children, the main clinical manifestations are rash, fever, nausea, vomiting, myalgia and bilateral arthralgia, mainly in the phalanges, wrists and ankles. The diagnosis is performed mainly through the patient's clinic, requiring a good anamnesis to identify the main risk conditions. OBJECTIVE: To describe the epidemiological profile of pediatric hospitalizations due to Chikungunya in Brazil, highlighting the main signs and symptoms associated with hospitalization. METHODS: An epidemiological, observational, analytical, cross-sectional study was carried out using data from the Disease Information and Notification System (SINAN-DATASUS) of the Ministry of Health regarding confirmed cases of Chikungunya that occurred in all units of the Brazilian federation, in the period from 2017 to 2021, among individuals aged 0 to 11 years. RESULT: A total of 287,898 patients were evaluated according to the geographical distribution of prevalence and factors associated with hospitalization, with fever, severe arthralgia, myalgia and headache being the most common symptoms. Also, the signs and symptoms that most increased hospitalizations were leukopenia, vomiting and petechiae. The rate of hospitalizations for Chikungunya in children aged 0 to 11 years was less than 3% and there were no deaths related to the infection. CONCLUSION: The evolution of Chikungunya in children, despite the association with comorbidities, signs and symptoms, was benign. The health professional must prevent the infection from progressing to hospitalizations, recognizing and intervening in the main signs that lead to this outcome.

show abstract

Arboviral diseases in pediatrics

Cited by 11 publications

References 38 publications

Persistent Joint Pain Following Arthropod Virus Infections

Persistent Joint Pain Following Arthropod Virus Infections

New traps for the capture of Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse) (Diptera: Culicidae) eggs and adults

Chikungunya Hospitalization In The Pediatric Population In Brazil: 2017-2021

Contact Info

Product

Resources

About